RxDoctor Payments Data

Kerin Adelson

Medical Oncology · Houston, TXNPI 1285846790

Payments from drug & device makers

$2,756,582in general payments, 2019–2025

Across 39 payments — averaging $70,682 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2.6M
  • Genentech, Inc.$80K
  • Radius Health, Inc.$25K
  • Astrazeneca UK Limited$13K
  • AstraZeneca$8K
  • AbbVie$7K
  • plus $11K from 7 others

What the payments were for

  • Consulting fees$15,27074%
  • Speaking & faculty fees$5,34726%
  • Education$230%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,756,582 in reported general payments places this provider in the 80th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas

Other medical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →